ArticleNature communications2024

HER2-targeting antibody drug conjugate FS-1502 in HER2-expressing metastatic breast cancer: a phase 1a/1b trial.

Qiao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.